During the past decade, APDP - Associação Protectora dos Diabéticos de Portugal conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "APDP - Associação Protectora dos Diabéticos de Portugal" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "AstraZeneca" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Associacao Protectora dos Diabeticos de Portugal" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "APDP - Associação Protectora dos Diabéticos de Portugal" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "APDP - Associação Protectora dos Diabéticos de Portugal" are "Diabetes Mellitus, Type 2" (4 trials), "Diabetic Nephropathies" (2 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes Mellitus Type 2" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "APDP - Associação Protectora dos Diabéticos de Portugal" in a lesser frequency.

Most popular intervention types in "APDP - Associação Protectora dos Diabéticos de Portugal" are "Drug" (10 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "BI 690517" (2 trials), "Empagliflozin" (2 trials), "BI 685509" (1 trials) and "Continuous Glucose Monitoring (CGM)" (1 trials). Other intervention names were less common.

The vast majority of trials in "APDP - Associação Protectora dos Diabéticos de Portugal" are 11 trials for "All" genders.

Currently, there are NaN active trials in "APDP - Associação Protectora dos Diabéticos de Portugal". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in APDP - Associação Protectora dos Diabéticos de Portugal, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in APDP - Associação Protectora dos Diabéticos de Portugal, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".